HomeANIK • NASDAQ
add
Anika Therapeutics Inc
Previous close
$11.45
Day range
$11.38 - $11.65
Year range
$10.89 - $29.12
Market cap
165.21M USD
Avg Volume
68.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 26.17M | -9.83% |
Operating expense | 18.96M | -11.71% |
Net income | -4.87M | -7.95% |
Net profit margin | -18.62 | -19.74% |
Earnings per share | -0.06 | -166.67% |
EBITDA | -2.69M | -509.05% |
Effective tax rate | -2.30% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.37M | -22.23% |
Total assets | 190.60M | -27.73% |
Total liabilities | 42.21M | -23.55% |
Total equity | 148.40M | — |
Shares outstanding | 14.34M | — |
Price to book | 1.11 | — |
Return on assets | -5.45% | — |
Return on capital | -6.05% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.87M | -7.95% |
Cash from operations | -130.00K | -3.17% |
Cash from investing | 1.67M | 192.48% |
Cash from financing | -5.44M | -139.24% |
Net change in cash | -3.79M | 10.62% |
Free cash flow | 2.61M | -27.80% |
About
Founded
1983
Headquarters
Website
Employees
288
